V8 Peptides — Engineered Performance
Research Library
GHK-Cu and KPV Blend: A Research Overview
GHK-KPVStacks

GHK-Cu and KPV Blend: A Research Overview

V8 Peptides Research TeamUpdated

Compiled from peer-reviewed literature and manufacturer analytical data for laboratory research reference.

Quick answer

What is the GHK-Cu + KPV blend in research? It is a lyophilized preparation that combines two unrelated tripeptides: glycyl-histidyl-lysine bound to copper (GHK-Cu), studied mainly in extracellular-matrix and gene-expression models, and Lys-Pro-Val (KPV), the C-terminal tripeptide of α-MSH, studied in inflammation-signaling and epithelial-uptake models. The two share a length, not a mechanism. Because the vial holds two analytes, identity and purity data should address both, and any result seen with the blend can only be attributed to a component by running each alone. Size, purity and storage details are on the blend product page; use the reconstitution calculator for arithmetic.

Two three-residue peptides in one vial look like a simple object, but they come from very different research traditions. One is a copper-binding plasma tripeptide first described in the 1970s. The other is a fragment of a pituitary hormone studied for how it dampens inflammatory signaling. This overview takes the blend apart component by component, explains what a researcher should and should not infer from a combined preparation, and lists what to record when one is used. For the broader background on the combined molecule and its naming, see the GHK-KPV research overview. This material is supplied for laboratory research use only; not for human consumption.

What the product page lists

The GHK-Cu + KPV product page describes a research blend that pairs copper tripeptide with KPV, supplied as a single 60 mg lyophilized vial in sealed clear glass with purity stated as ≥98% (HPLC). The molecular formula field reads simply “Blend”, and the sequence and identity field points to the certificate of analysis where one has been published. That last point is the practical one: a blend has no single formula, so identity comes from a document, not from a label.

FieldProduct page entryWhat it means for the bench
Size60 mg blendTotal mass of both peptides; the split between components is not a number to assume
Purity≥98% (HPLC)A chromatographic figure; for a blend, ask whether it describes each peak or the sum
FormLyophilized powderStable dry state; reconstitution starts the stability clock for both peptides
StorageRefrigerate at 2–8 °C; −20 °C for long-term; protect from heat, moisture and lightTwo storage tiers used in the handling section below
ContainerSealed clear glass research vialNo light protection of its own; keep it boxed
DocumentationCertificate of analysis, where publishedCheck the COA library for the lot before relying on any figure

If a lot-specific certificate is not yet listed, record that in the receiving log and regard the identity of both components as unconfirmed until it is. How to read a COA walks through the fields a certificate should contain.

Component one: GHK-Cu

GHK is the tripeptide glycyl-L-histidyl-L-lysine. Pickart and colleagues identified it in human plasma in the early 1970s as a factor that changed the behavior of liver cells in culture, and a 1980 report proposed that it works by facilitating copper uptake into cells (Pickart et al., 1980). The histidine imidazole, the N-terminal amine and a backbone amide nitrogen coordinate Cu(II) in a square-planar arrangement, a geometry established by spectroscopic work in solution (Freedman et al., 1982). It is the complex, not the free tripeptide, that most laboratory papers study.

Research uses cluster around three areas: matrix-enzyme expression in fibroblast cultures (Siméon et al., 2000), gene-expression profiling of cells exposed to the peptide, and redox behavior of the copper center. Pickart and Margolina (2018) reviewed the gene-expression data and the reported effects on tissue-remodeling pathways. Readers who want the full picture can start with the GHK-Cu research overview and the GHK-Cu product page.

Component two: KPV

KPV is Lys-Pro-Val, residues 11–13 of α-melanocyte-stimulating hormone. The KPV product page lists a molecular formula of C16H30N4O4. Early work found that this fragment retained anti-inflammatory activity in animal models even though it lacks the central His-Phe-Arg-Trp sequence that the melanocortin receptors recognize (Catania et al., 2004). A later study reported that KPV is carried into intestinal epithelial cells by the peptide transporter PepT1 and that it reduced inflammatory signaling in colitis models in mice (Dalmasso et al., 2008).

The takeaway is that KPV is studied through epithelial uptake and inhibition of pro-inflammatory transcription, not through classical receptor agonism. The KPV research overview and the PepT1 uptake background article go into that in depth.

Why the two are paired in a vial

The pairing rests on a design idea, not on a combined result. GHK-Cu is read out in matrix- and oxidative-stress-related endpoints; KPV is read out in inflammatory-signaling endpoints. A single model that stresses both, for example a fibroblast or keratinocyte culture exposed to an inflammatory stimulus, could in principle ask whether the two readouts interact. A pre-mixed vial makes a fixed-ratio preparation convenient, but convenience is also its limit: you cannot vary the ratio, and you cannot separate the components without a second vial.

QuestionBlend aloneBlend plus single-component arms
Does the preparation change the endpoint?Yes or noYes or no, with the comparator
Which component carries the change?Cannot be toldCan be assigned
Is the effect additive or interactive?Cannot be toldTestable with a factorial layout
Is vehicle or counter-ion responsible?Cannot be toldTestable with a vehicle arm

That is why published combination work generally includes single-agent arms; the logic is set out in the synergy-methodology papers cited below (Chou, 2010; Foucquier and Guedj, 2015).

Chemistry that matters when two peptides share a vial

Copper does not stay with its own peptide by decree

Cu(II) binds GHK tightly but not irreversibly. In a solution that also contains another peptide, trace free copper or weakly bound copper can interact with other side chains, most obviously histidine, methionine, cysteine and lysine. KPV has lysine and no histidine, methionine or cysteine, so it offers few strong competing sites, which is one reason the pairing is chemically less awkward than a copper peptide mixed with a histidine- or methionine-rich partner. It is still an assumption to verify, not a given, and the article on copper and other peptides in a blend explains how to check it.

Colour is part of the record

Copper-GHK solutions are blue, with intensity depending on concentration. A blend stock that has the expected pale blue tint is consistent with intact complex; a brown or green shift, or loss of colour, is a reason to stop and note the observation. KPV is colourless, so the colour reflects the copper component only.

Two chemistries, one pH

GHK-Cu complex stability depends on pH because the histidine and amide nitrogens must be deprotonated to bind copper, while KPV has no pH-sensitive coordination at all. A stock buffered far from neutral is a bigger risk for the copper complex than for KPV, so pH is chosen around the more demanding component.

Handling the blend in the laboratory

Handling follows the general rules for lyophilized peptides, described in how to reconstitute a lyophilized peptide: equilibrate the sealed vial to room temperature before opening, run the diluent down the glass wall, swirl rather than shake, and keep the stock cold. Both tripeptides are small and hydrophilic, so dissolution is usually quick and foaming is minor compared with a lipidated peptide.

Concentration arithmetic is a formula, not a table: stock concentration in mg/mL equals total vial mass in mg divided by diluent volume in mL, and the molar concentration of any one component equals its mass concentration divided by its molar mass. Because the product page gives only the blend’s total mass, a molar figure for an individual component can be computed only if the component masses are documented for the lot. The calculator handles the volume side.

Handling stepReasonRecord
Equilibrate sealed vialAvoids condensation on the cold cakeTime out of storage
Add diluent along the wallLimits foaming and local over-concentrationDiluent type, lot, volume
Swirl, then standGentle dissolutionAppearance, colour, clarity
Aliquot and labelAvoids repeated freeze–thaw of the whole stockAliquot count and volume
Store cold, protected from lightSlows hydrolysis and oxidationLocation and temperature

What to document and what not to conclude

A defensible methods section for work with this blend states the lot, the date, the diluent, the stock concentration as a formula result, the storage tier and the number of freeze–thaw cycles. It also states that the preparation contains two peptides and says what control arms were used. It does not claim that an observed effect belongs to one peptide or the other unless an arm tests it, and it does not describe the blend as a validated model system. Negative and mixed results belong in the record: a combined preparation that does nothing beyond a single component is informative.

For related reading, the GHK-Cu versus KPV comparison sets the two components side by side, and GHK-KPV purity testing explains the analytical side. The overview of peptide blends and research stacks places this blend among larger multi-peptide preparations.

Frequently asked questions

What is in the GHK-Cu + KPV blend?

Per the product page, a lyophilized research blend of GHK-Cu copper tripeptide and KPV, supplied as a 60 mg vial with ≥98% HPLC purity stated. The split between the two components is documented on the lot paperwork, not assumed.

Is this one new molecule or two peptides?

The product page describes it as a blend of two peptides. Literature on a covalently joined GHK-KPV also exists as a naming question, which the GHK-KPV overview discusses; this page deals with the blend as listed.

Why is GHK-Cu blue?

The copper(II) ion bound to the histidine, amine and amide nitrogens absorbs light in the visible range. The blue-to-pale-blue tint of the solution is a convenient indicator that the complex is present.

How is KPV thought to enter cells?

A published murine and cell-culture study reported uptake through the PepT1 transporter in intestinal epithelial cells (Dalmasso et al., 2008).

Can a blend show synergy?

Synergy is a defined quantitative concept requiring single-agent arms and a reference model. A blend alone cannot demonstrate it; see Chou (2010) and Foucquier and Guedj (2015).

How should the vial be stored?

As stated on the product page: refrigerate at 2–8 °C, hold at −20 °C for long-term storage, and protect from heat, moisture and light.

What diluent suits the blend?

Sterile water suits a stock that is aliquoted and frozen promptly; bacteriostatic water suits a stock vial entered several times. Run a matched vehicle control in cell work either way.

How do I compute the stock concentration?

Divide the vial mass in mg by the diluent volume in mL to get mg/mL for the total blend. Per-component molar values need the component masses for the lot. The reconstitution calculator does the volume arithmetic.

What should a COA for a blend show?

Identity and purity evidence for each component, the lot number and the test date. Where no lot certificate is listed yet, record that rather than assuming.

Where can I read more on each component?

The GHK-Cu and KPV research overviews and the GHK-KPV overview in the research library cover history, mechanism and handling in depth.

Related reading: GHK-Cu + KPV vs Other Research Peptide Combinations, GHK-Cu vs KPV: Stability, Temperature, pH and Storage, GHK-Cu and KPV Synergy: What the Literature Supports.

References

  1. Pickart L, Freedman JH, Loker WJ, et al. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature. 1980;288:715-717. doi:10.1038/288715a0
  2. Freedman JH, Pickart L, Weinstein B, Mims WB, Peisach J. Structure of the glycyl-L-histidyl-L-lysine-copper(II) complex in solution. Biochemistry. 1982;21(19):4540-4544. doi:10.1021/bi00262a004
  3. Siméon A, Emonard H, Hornebeck W, Maquart FX. The tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci. 2000;67(18):2257-2265. doi:10.1016/s0024-3205(00)00803-1
  4. Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987. doi:10.3390/ijms19071987
  5. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-178. doi:10.1053/j.gastro.2007.10.026
  6. Catania A, Gatti S, Colombo G, Lipton JM. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev. 2004;56(1):1-29. doi:10.1124/pr.56.1.1
  7. Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70(2):440-446. doi:10.1158/0008-5472.CAN-09-1947
  8. Foucquier J, Guedj M. Analysis of drug combinations: current methodological landscape. Pharmacol Res Perspect. 2015;3(3):e00149. doi:10.1002/prp2.149

Research Use Only. All products are sold strictly for laboratory research and development purposes only. Not for human or animal consumption. Not a drug, food, or cosmetic. By purchasing, you affirm you are a qualified researcher or institution.